Patricia Kelly, MD
Cardiovascular Disease · Missoula, MTNPI 1831149269
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,625 of the $12,405 with a category attached, or 85.6%. 23 manufacturers reported payments, led by Medtronic at 51.1% of the total. Reporting peaked in 2023 at $6,363 and has fallen 95.0% since, to $318 in 2025. Among cardiovascular disease clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $133.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- ZOLL Respicardia, Inc.$5K
- Amgen$458
- Bayer$369
- Johnson & Johnson$118
- AstraZeneca$80
- plus $536 from 17 others
What the payments were for
- Consulting fees$10,62586%
- Food & beverage$1,78014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 7 | $6,344 |
| ZOLL Respicardia, Inc. | 2 | $4,500 |
| Amgen | 25 | $458 |
| Bayer | 13 | $369 |
| Johnson & Johnson | 8 | $118 |
| AstraZeneca | 6 | $80 |
| Novartis | 4 | $65 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $52 |
| Actelion Pharmaceuticals US, Inc. | 3 | $49 |
| Baxter Healthcare | 3 | $47 |
| Novo Nordisk | 3 | $43 |
| Boehringer Ingelheim | 3 | $43 |
| Amarin Pharma, Inc. | 3 | $38 |
| Preventice Services, LLC | 1 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| GSK | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Merck | 1 | $12 |
| Mylan Specialty L.p. | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$4,500
- Kerendia$120
How this compares
$12,405 in reported general payments places this provider in the 90th percentile of 49 cardiovascular disease providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nebivolol Hcl | 31 | $871 |
| Metoprolol Succinate | 16 | $463 |
| Potassium Chloride | 17 | $378 |
| Bisoprolol Fumarate | 11 | $332 |
| Amlodipine Besylate | 16 | $261 |
| Chlorthalidone | 13 | $228 |
| SotalolSotalol Hcl | 11 | $170 |
| Lisinopril | 15 | $158 |
| Olmesartan Medoxomil | 14 | $111 |
| Hydralazine Hcl | 13 | $69 |
| Clonidine Hcl | 13 | $62 |
| Carvedilol | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Missoula
- Jocelyn SpoonMissoula$17K
- Newton CoutinhoMissoula$10K
- Michael ReedMissoula$8K
- Gregory WoodMissoula$6K
- Morgan KelloggMissoula$4K
- Ashley MaysMissoula$4K
- Matthew WeissMissoula$3K
- Puneet BansalMissoula$2K
- Alexander JehleMissoula$2K
- Jon McGregorMissoula$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.